Director/PDMR Shareholding

RNS Number : 1912A

Assura PLC

17 January 2020

 

17 January 2020

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company has been notified that in respect of the interim dividend paid on 15 January 2020, the following PDMRs acquired ordinary shares of 10 pence each in the Company through their participation in the Company's Scrip Dividend Alternative:

PDMR	Date Acquired	Number of shares acquired	Purchase price per Share
Ed Smith	15 January 2020	834	£0.77
Jayne Cottam	15 January 2020	835	£0.77

The Notification of Dealing Form for Mr Smith and Mrs Cottam can be found below.

This notification is made in accordance with the Market Abuse Regulation.

-ENDS-

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ed Smith
2	Reason for the notification
a)	Position/status	Chairman
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares under the Scrip Dividend Alternative
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.77 GBP 834
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.77 GBP 834 £642.18 GBP
e)	Date of the transaction	15 January 2020
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares under the Scrip Dividend Alternative
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.77 GBP 835
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.77 GBP 835 £642.95 GBP
e)	Date of the transaction	15 January 2020
f)	Place of the transaction	XLON

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, Company Secretary David Purcell, Head of Financial Reporting
Finsbury Gordon Simpson James Thompson	Tel: [phone]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF7

 

END

 

 

DSHBBGDBSDBDGGR